PD-L1 expressed in tumour cells, in particular, is involved in the immune surveillance evasion, binding the cell-surface receptor PD-1 expressed by T cells and generating an inhibitory signal that attenuates the activity of T cells29. Here, CD177 is linked to neoplasm.